Recombinant Xenopus tropicalis Protein arginine N-methyltransferase 2 (prmt2)

What is the structure and function of Xenopus tropicalis PRMT2?

PRMT2 belongs to the protein arginine N-methyltransferase family that catalyzes the formation of monomethylarginine (MMA) and asymmetric dimethylarginine (aDMA) on histone substrates, particularly histone H4. The protein contains several key structural domains:

• SAM-binding Rossmann fold for binding the methyl donor S-adenosylmethionine

• Peptide-binding groove for substrate interaction

• Dimerization arm that facilitates homodimer formation

• N-terminal Src-homology 3 (SH3) domain unique to PRMT2 among PRMTs

The SH3 domain is connected to the rest of PRMT2 through a highly flexible linker as shown by AlphaFold structural predictions. This domain binds polyproline stretches on proteins involved in splicing and cell scaffolding . In Xenopus development, PRMT2 facilitates asymmetric dimethylarginine formation on histone H3 at arginine 8 (H3R8me2a) at promoter sites for transcriptional activation .

How does Xenopus tropicalis serve as a model organism for PRMT2 research?

Xenopus tropicalis offers several advantages as a model organism for studying PRMT2:

• Diploid genome (~1.5 Gbp) compared to the allotetraploid X. laevis (~3.1 Gbp)

• Shorter generation time (developmental milestones occur approximately twice as fast as in X. laevis)

• Smaller embryo size (~0.8mm diameter versus ~1.2mm for X. laevis)

• More amenable to genetic manipulation and transgenic approaches

The developmental timeline of X. tropicalis includes:

These features make X. tropicalis particularly suitable for studies requiring genetic manipulation, multigenerational approaches, and functional genomics while maintaining the advantages of Xenopus as a classic embryological system .

What experimental approaches are used to study PRMT2 activity?

Several experimental approaches are employed to study PRMT2 activity:

• Differential scanning fluorimetry (DSF) to evaluate:

  • Binding to histone peptides and other ligands

  • Interactions with other PRMTs, particularly PRMT1

  • Effects of mutations on protein stability

  • Conformational changes upon ligand binding

• In vitro methylation assays using:

  • Histone peptides

  • Individual histones (H2A, H3, and H4)

  • Histone octamers

  • Mononucleosomes

• Protein-protein interaction studies:

  • Native PAGE analysis with fluorescently tagged PRMT1/2 enzymes

  • Thermal shift assays to detect heteromeric protein-protein interactions

  • Domain deletion approaches to assess the contribution of specific domains (e.g., SH3 domain)

• Transgenic approaches in X. tropicalis:

  • Stable transgenic lines for in vivo reporting

  • Binary constructs like GAL4/UAS systems for experimental manipulation of gene expression

How does PRMT2 interact with PRMT1 to regulate histone methylation?

PRMT2 demonstrates an important noncatalytic role in histone methylation through its interaction with PRMT1. Research has revealed several key aspects of this interaction:

• PRMT2 modulates the substrate specificity of PRMT1 in a cofactor- and domain-dependent manner.

• A 10-fold excess of PRMT2 promotes PRMT1 methylation of both histone H4 and histone H2A.

• Equimolar or 10-fold excess of PRMT2 relative to PRMT1 improves the catalytic efficiency of PRMT1 towards individual histone substrates H2A, H3, and H4.

• PRMT2 enhances PRMT1 activity marginally on histone octamers but significantly improves methylation of mononucleosomes when present in 10-fold excess.

This interaction appears to be mediated through the SH3 domain of PRMT2, as this domain is crucial for protein-protein interactions and removal of the SH3 domain reduces both substrate interaction and catalytic activity .

What is the significance of PRMT2's thermal stability characteristics?

PRMT2 exhibits unique thermal stability characteristics that provide insights into its structure and function:

• Biphasic melting curve: PRMT2 shows two discrete melting transitions (Tm1 and Tm2), suggesting the presence of distinct conformational populations or oligomeric states.

• Concentration-dependent stability: PRMT2 demonstrates concentration-dependent positive changes in melting temperature values, indicating changes to the oligomeric state at higher concentrations.

• Buffer effects: Glycerol in the storage buffer partially stabilizes PRMT2, causing Tm2 to become the major transition peak.

• Histone peptide binding: All tested histone peptides cause a dose-dependent condensation of the two melting populations into a single Tm with concomitant thermal stabilization, indicating significant structural changes upon substrate binding.

• PRMT1 interaction: When PRMT2 is mixed with PRMT1, the thermal melt changes, indicating formation of PRMT1/2 complexes with distinct stability properties .

These thermal properties not only provide insights into PRMT2's structural dynamics but also offer methodological approaches for studying protein-protein and protein-substrate interactions.

How do mutations in the SAM-binding domain affect PRMT2 function?

The H112Q mutation in the SAM-binding domain of PRMT2 has been studied to understand the relationship between catalytic activity and protein interactions:

• The H112Q mutation inhibits PRMT2 catalytic activity in cells and has been linked to oncogenic effects in various cancers.

• PRMT2H112Q displays altered thermal stability properties:

  • It maintains the biphasic melting characteristics of wild-type PRMT2

  • The second melting transition becomes too broad to accurately define

  • Its first melting temperature (Tm1) is 2.4°C lower than wild-type PRMT2

  • The melt shows lower raw fluorescence with more gradual transitions

• When mixed with PRMT1, PRMT2H112Q produces a distinct thermal profile:

  • A small shoulder (Tm1) that is 1.61°C lower than PRMT2H112Q alone

  • A major peak (Tm2) that is 0.9°C higher than PRMT1 Tm1

• In the presence of SAH or H3 peptide, the PRMT1/PRMT2H112Q mixture yields biphasic curves without significant thermal stability differences compared to individual PRMT melts .

These findings suggest that mutations in the SAM-binding domain affect both PRMT2's catalytic function and its thermal stability characteristics, potentially altering its interaction with other PRMTs and substrates.

What role does PRMT2 play in epigenetic regulation during Xenopus development?

PRMT2 contributes to epigenetic regulation during Xenopus development through several mechanisms:

• It facilitates asymmetric dimethylarginine formation on histone H3 at arginine 8 (H3R8me2a) at promoter sites for transcriptional activation during Xenopus development .

• The timing of PRMT2 activity aligns with zygotic genome activation (ZGA), which occurs around 4-4.5 hours post-fertilization (stages 8-9) in X. tropicalis .

• PRMT2 overexpression and the H3R8me2a mark have been linked to oncogenic transcriptional programming in multiple cancers, suggesting its role in gene expression regulation is significant and can be dysregulated in disease states .

• PRMT2's function as a transcriptional coactivator of several nuclear receptors further supports its role in gene expression regulation during development .

Given that the maternal-to-zygotic transition involves a handoff in genetic control from maternal to embryonic factors, epigenetic regulators like PRMT2 likely contribute to establishing the chromatin environment necessary for proper developmental gene expression patterns.

How does the SH3 domain contribute to PRMT2 function?

The N-terminal Src-homology 3 (SH3) domain is a unique feature of PRMT2 among PRMTs and significantly contributes to its function:

• Structural context: The SH3 domain is attached to the rest of PRMT2 through a highly flexible linker, as shown by AlphaFold structural predictions (Fig. S1 in the referenced study).

• Protein interaction: The SH3 domain binds polyproline stretches on proteins involved in splicing and cell scaffolding.

• Substrate recognition: Removal of the SH3 domain results in loss of interaction between PRMT2 and its methylation substrate hnRNP E1B-AP5 in cultured cells.

• Catalytic contribution: Removal of the SH3 domain further reduces the already low catalytic activity of PRMT2.

• PRMT1 interaction: The SH3 domain may be important for PRMT2's interaction with PRMT1, allowing PRMT2 to enhance PRMT1's methyltransferase activity.

• Transcriptional coactivation: The SH3 domain may contribute to PRMT2's function as a transcriptional coactivator of nuclear receptors .

These findings suggest that the SH3 domain plays a crucial role in PRMT2's function beyond direct catalytic activity, potentially serving as a protein interaction module that facilitates PRMT2's noncatalytic roles in histone methylation and transcriptional regulation.

What optimization strategies improve differential scanning fluorimetry for PRMT2 studies?

Differential scanning fluorimetry (DSF) for PRMT2 studies requires several optimization considerations:

• Addressing biphasic melting patterns:

  • Monitor both melting transitions (Tm1 and Tm2)

  • Consider the effects of protein concentration on the relative proportions of each transition

  • Standardize conditions to maintain consistent baseline melting profiles

• Protein concentration optimization:

  • Recognize that PRMT2 exhibits concentration-dependent changes in melting temperature

  • Use consistent protein concentrations when comparing different experimental conditions

  • Consider how concentration might affect oligomeric state

• Buffer composition effects:

  • Control glycerol percentage in storage buffers, as it affects thermal stabilization

  • Standardize buffer components to minimize batch-to-batch variability

  • Document any variations in storage conditions that might affect results

• Ligand controls:

  • Include controls for histone peptides without PRMT2, as they exhibit melting characteristics with the fluorescent dye (though with 10-fold lower fluorescence)

  • Establish appropriate baseline measurements for different ligand types

• Domain-specific analyses:

  • Compare full-length PRMT2 with domain deletion variants (e.g., SH3 deletion)

  • Analyze the effects of point mutations (e.g., H112Q) on thermal stability profiles

  • Monitor how different domains contribute to ligand binding and protein-protein interactions

How can researchers distinguish between catalytic and non-catalytic PRMT2 functions?

Distinguishing between PRMT2's catalytic and non-catalytic functions requires specialized experimental approaches:

• Catalytically inactive mutants:

  • Generate the H112Q mutation in the SAM-binding domain to inhibit PRMT2's enzymatic activity

  • Compare the effects of wild-type vs. H112Q PRMT2 on histone methylation patterns

  • Assess whether PRMT2H112Q can still enhance PRMT1 activity

• Domain-specific studies:

  • Create SH3 domain deletion variants to assess how this domain contributes to both direct catalytic activity and enhancement of other PRMTs

  • Generate chimeric proteins with SH3 domains from other proteins to test domain-specific functions

• Comparative activity assays:

  • Measure PRMT2's direct methyltransferase activity on various substrates

  • Assess how PRMT2 affects PRMT1 activity on the same substrates

  • Vary PRMT2:PRMT1 ratios (equimolar, 10-fold excess) to determine dose-dependent effects

• Histone substrate variation:

  • Test different forms of histones (peptides, individual histones, octamers, mononucleosomes)

  • Determine whether PRMT2's effects differ based on substrate complexity

  • The research indicates that PRMT2 enhancement of PRMT1 activity is more pronounced with mononucleosomes compared to histone octamers

What are the appropriate controls for studying X. tropicalis PRMT2 in methylation assays?

Robust methylation assays for X. tropicalis PRMT2 require multiple control conditions:

• Enzyme controls:

  • PRMT2 alone at various concentrations

  • Catalytically inactive PRMT2 (H112Q mutant)

  • PRMT2 with SH3 domain deleted

  • PRMT1 alone (as a positive control with higher activity)

  • PRMT1 with inactive PRMT2 to control for non-specific protein effects

• Substrate controls:

  • Histone peptides of different compositions

  • Individual histone proteins (H2A, H3, H4)

  • Histone octamers

  • Mononucleosomes

  • Non-histone substrates to assess specificity

• Reaction condition controls:

  • With and without SAM (S-adenosylmethionine) as the methyl donor

  • With SAH (S-adenosylhomocysteine) to inhibit methyltransferase activity

  • Varying concentrations of enzyme and substrate

  • Different PRMT1:PRMT2 ratios (equimolar, 10-fold excess)

• Analytical controls:

  • Baseline methylation levels for each substrate

  • Time course to ensure linearity of reaction

  • Appropriate negative controls (reaction without enzyme, without SAM)

What experimental challenges arise when expressing recombinant X. tropicalis PRMT2?

Expression and purification of recombinant X. tropicalis PRMT2 presents several experimental challenges:

• Expression system selection:

  • Bacterial systems may not provide proper folding or post-translational modifications

  • Insect cell or mammalian expression systems may be needed for fully functional protein

  • The choice of expression system affects protein yield and functional characteristics

• Protein solubility:

  • PRMT2's complex domain structure (including the SH3 domain and catalytic core) may affect solubility

  • Buffer optimization is crucial to maintain protein stability during purification

  • Addition of glycerol improves stability but affects thermal properties

• Oligomeric state variability:

  • PRMT2 shows concentration-dependent changes in thermal stability, suggesting changes in oligomeric state

  • Purification methods should account for potential oligomer formation

  • Analytical techniques should be used to characterize the oligomeric state of the purified protein

• Domain integrity:

  • The flexible linker connecting the SH3 domain to the catalytic core may be susceptible to proteolysis

  • Verification of full-length protein integrity is essential

  • Domain-specific antibodies can help confirm the presence of all structural elements

• Catalytic activity assessment:

  • PRMT2 exhibits low catalytic efficiency compared to other PRMTs

  • Sensitive detection methods are required to measure enzymatic activity

  • The enhancement of PRMT1 activity may be a more reliable readout than direct PRMT2 activity

How can researchers effectively study PRMT2's role in X. tropicalis development?

To effectively study PRMT2's developmental role in X. tropicalis, researchers should consider:

• Gene manipulation approaches:

  • CRISPR/Cas9 genome editing to generate PRMT2 knockout or point mutations

  • Morpholino oligonucleotides for transient PRMT2 knockdown

  • Transgenic overexpression of wild-type or mutant PRMT2

  • X. tropicalis is particularly suitable for genetic manipulation due to its diploid genome and shorter generation time

• Developmental timing considerations:

  • Focus on zygotic genome activation (occurring around 4-4.5 hours post-fertilization)

  • Monitor early developmental transitions when epigenetic reprogramming occurs

  • Consider stage-specific effects given PRMT2's role in transcriptional activation

• Histone modification analysis:

  • ChIP-seq to map H3R8me2a distribution across the genome at different developmental stages

  • Compare wild-type with PRMT2-depleted or overexpressing embryos

  • Integrate with transcriptome data to correlate histone modifications with gene expression

• Protein interaction studies:

  • Identify PRMT2-interacting partners during development

  • Assess PRMT1-PRMT2 interactions in vivo

  • Determine whether SH3 domain interactions change during development

• Rescue experiments:

  • Test whether wild-type PRMT2 can rescue developmental defects in PRMT2-depleted embryos

  • Determine if catalytically inactive PRMT2 (H112Q) can rescue through non-catalytic functions

  • Assess whether PRMT2 without the SH3 domain can rescue specific aspects of the phenotype